« Previous
Next »
Titles
- Gathering and spreading knowledge: publications and the Army Medical Library around World War I1
- General clinical pharmacology considerations for neonatal studies for drugs and biological products1
- General considerations for animal studies intended to evaluate medical devices: guidance for industry and Food and Drug Administration staff1
- General principles for evaluating the abuse deterrence of generic solid oral opioid drug products1
- General principles for evaluating the human food safety of new animal drugs used in food-producing animals1
- Generic Drug User Fee Amendments of 2012: questions and answers related to self-identification of facilities, review of generic drug submissions, and inspections and compliance1
- Generic drug development: stakeholders’ views of risk evaluation and mitigation strategies differ : report to the Chairman, Committee on Energy and Commerce, House of Representatives1
- Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate1
- Generic drugs: FDA should make public its plans to issue and revise guidance on nonbiological complex drugs : report to Congressional requesters1
- Generic drugs: Stakeholder views on improving FDA’s information on patents : report to congressional committees1
- Genetic analysis of mammalian signaling pathways that activate STATs and NFkB1
- Geographic disparities affect access to buprenorphine services for opioid use disorder1
- Geographic expansion of Medicaid managed care organizations: assessing access to primary care in nonmetropolitan counties1
- Georgia could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control1
- Germs or embryos of four vertebrates1
- Getting started with community-based outreach1
- Global health security: USAID and CDC funding, activities, and assessments of countries’ capacities to address infectious disease threats before COVID-19 onset : report to Congressional committees1
- Glossary of terms used in the Fred L. Soper exhibit1
- Glossary of terms used in the Oswald T. Avery exhibit1
- Good manufacturing practice considerations for responding to COVID-19 infection in employees in drug and biological products manufacturing1